There are 2934 resources available
1857 - A Phase 1a/2a Trial of Sym015 - a MET Antibody Mixture - in Patients with Advanced Solid Tumors
Presenter: D. Ross Camidge
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract
Poster Discussion session - Basic science - Invited Discussant 5PD, 6PD, 7PD and 1982PD
Presenter: Sheila Singh
Session: Poster Discussion session - Basic science
Resources:
Slides
Webcast
Poster Discussion session - Basic science - Invited Discussant 8PD, 1983PD and 1984PD
Presenter: Thomas Helleday
Session: Poster Discussion session - Basic science
Resources:
Slides
Webcast
Poster Discussion session - Basic science - Invited Discussant 9PD, 1985PD and 1986PD
Presenter: Joan Seoane
Session: Poster Discussion session - Basic science
Resources:
Slides
Webcast
Poster Discussion – NSCLC, metastatic - Invited Discussant 1483PD, LBA82, LBA83 and LBA84
Presenter: Federico Cappuzzo
Session: Poster Discussion – NSCLC, metastatic
Resources:
Slides
Webcast
Poster Discussion – NSCLC, metastatic - Invited Discussant 1484PD, 1485PD, 1486PD and 1487PD
Presenter: Fiona Blackhall
Session: Poster Discussion – NSCLC, metastatic
Resources:
Slides
Webcast
Poster Discussion – NSCLC, metastatic - Invited Discussant 1488PD, 1489PD, 1490PD and LBA85
Presenter: Ross Soo
Session: Poster Discussion – NSCLC, metastatic
Resources:
Slides
Webcast
2239 - Final efficacy results from B-F1RST, a prospective Phase II trial evaluating blood-based tumour mutational burden (bTMB) as a predictive biomarker for atezolizumab (atezo) in 1L non-small cell lung cancer (NSCLC)
Presenter: Mark Socinski
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract
2584 - Primary results from TAIL, a global single-arm safety study of atezolizumab (atezo) monotherapy in a diverse population of patients with previously treated advanced non-small cell lung cancer (NSCLC)
Presenter: Andrea Ardizzoni
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract
2685 - Longitudinal circulating tumour DNA (ctDNA) monitoring for early detection of disease progression and resistance in advanced NSCLC in FLAURA
Presenter: Jhanelle E. Gray
Session: Poster Discussion – NSCLC, metastatic
Resources:
Abstract